Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Product Development

Master protocols present systematic path forward for evaluating COVID-19 treatments

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 4, 2020 2:35 AM UTC
Updated on Apr 10, 2020 at 11:39 PM UTC

The globe is now scattered with small, investigator-led studies of COVID-19 candidate therapies, with no systematic way for regulators to determine which are safest and most beneficial. Master protocol trials can solve that problem by standardizing procedures and endpoints across multiple treatments.

At least four large-scale master protocol trials started recruiting patients in March. While they have different treatment arms and endpoints, they all share the goals of delivering head-to-head data on promising therapies quickly...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article